SCI
AGN

S&CO Inc’s Allergan plc AGN Stock Holding History

S&CO Inc’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,325
Closed -$728K – 184
2019
Q3 		$728K Sell
4,325
-2,600
-38% -$424K 0.08% 120
2019
Q2 		$1.16M Buy
6,925
+50
+0.7% +$6.92K 0.13% 101
2019
Q1 		$1.01M Buy
6,875
+600
+10% +$87K 0.11% 108
2018
Q4 		$839K Sell
6,275
-365
-5% -$59.8K 0.11% 112
2018
Q3 		$1.26M Buy
6,640
+930
+16% +$171K 0.14% 97
2018
Q2 		$952K Buy
5,710
+3,250
+132% +$522K 0.11% 112
2018
Q1 		$414K Buy
2,460
+170
+7% +$28.5K 0.05% 151
2017
Q4 		$375K Buy
2,290
+1,075
+88% +$193K 0.05% 150
2017
Q3 		$249K Hold
1,215
– – 0.03% 171
2017
Q2 		$295K Hold
1,215
– – 0.04% 160
2017
Q1 		$290K Hold
1,215
– – 0.04% 161
2016
Q4 		$255K Buy
+1,215
New +$252K 0.04% 168

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

S&CO Inc's AGN Position: Q4 2019 in Review

S&CO Inc sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 4,325 shares — an estimated $728K sold.

S&CO Inc first reported a position in AGN in Q4 2016 and held it in 12 quarters. The position peaked at $1.26M in Q3 2018. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • S&CO Inc reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • S&CO Inc sold 4,325 Allergan plc shares in Q4 2019, an estimated $728K.
  • S&CO Inc first reported a position in Allergan plc in Q4 2016 and held it in 12 quarters.
  • S&CO Inc's Allergan plc position peaked at $1.26M in Q3 2018.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on S&CO Inc's 13F filing for Q4 2019, filed 24 Jan 2020.